Skip to main content
NVDA+0.71%AAPL+0.57%MSFT-0.38%GOOGL+1.55%AMZN+1.94%TSM+3.07%SPCX+1.80%AVGO+3.94%META-1.29%TSLA+3.69%LLY+0.06%BRK-B-0.82%MU+3.14%SKHY+2.46%WMT-1.14%AMD+5.31%JPM+0.62%V-1.52%XOM-2.13%JNJ+0.91%ASMLa+2.80%MA-1.07%ABBV-0.09%INTC+3.21%1398.HK+2.15%CVX-1.44%0700.HK-0.31%COST-1.40%CSCO+1.03%KO-1.31%ORCL+4.53%UNH-0.14%PG-0.63%BAC+0.33%1816.HK+1.32%3988.HK+0.66%CAT+2.90%DELL+7.60%HD-0.08%PM+0.49%0857.HK-0.98%0939.HK+0.81%AMAT+1.99%AP2d+2.18%GE+3.35%1288.HK+0.60%LRCX+1.29%0005.HK-5.56%NVS+1.62%MS+2.07%NZDMXN+0.67%USDJPY+0.67%USDMXN+0.60%EURUSD-0.60%AUDJPY+0.57%AUDDKK+0.52%EURAUD-0.50%EURZAR-0.50%GBPUSD-0.44%USDCHF+0.43%EURSEK-0.43%GBPTRY+0.41%EURCNH-0.40%NZDJPY+0.40%GBPZAR-0.36%EURHKD-0.36%CADJPY+0.35%EURNZD-0.35%GBPAUD-0.35%AUDCHF+0.35%USDDKK+0.35%EURSGD-0.34%USDCAD+0.33%GBPHKD+0.32%GBPMXN-0.28%USDPLN+0.27%AUDNOK+0.27%NZDUSD-0.26%EURCAD-0.26%CHFJPY+0.25%SGDJPY+0.25%EURNOK-0.25%AUDCAD+0.23%GBPJPY+0.21%GBPSGD-0.20%EURCHF-0.18%CHFSEK-0.18%GBPNZD-0.18%AUDSGD+0.18%USDTRY+0.18%NZDCHF+0.16%USDILS+0.16%NOKJPY+0.16%AUDNZD+0.16%EURGBP-0.15%USDZAR-0.14%GBPCAD-0.13%USDNOK+0.10%CADCHF+0.10%AUDUSD-0.09%CHFSGD-0.09%USDSEK-0.08%EURPLN-0.08%EURJPY+0.08%NZDSGD+0.08%NZDCAD+0.06%USDCNH-0.05%EURCZK-0.04%USDHKD+0.04%USDCOP-0.04%GBPCHF-0.03%USDTHB-0.02%USDSGD+0.01%CHFNOK+0.01%PLNJPY-0.01%EURDKK0.00%HG1+1.70%USOIL-1.24%XNGUSD-1.14%XAUUSD+0.97%GAUUSD+0.97%UKOIL-0.87%XAGUSD+0.47%GAGUSD+0.47%XPTUSD+0.09%SUGAR0.00%COTTON0.00%C10.00%BTCUSD+0.73%ETHUSD+23.96%USDTUSD+0.06%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.16%ZECUSDT+5.59%DOGEUSD+20.65%XMRUSDT+0.37%LINKUSD+25.58%BCHUSDT+3.29%XLMUSD+0.44%UNIUSD-0.51%LTCUSD+17.89%SUIUSD+0.88%HBARUSDT-1.75%TONUSD+41.71%TAOUSDT+0.59%AAVEUSD-2.45%DOTUSDT-0.79%ICPUSDT-1.33%ONDOUSDT+0.41%WLDUSDT+0.37%ARBUSDT-0.06%JUPUSDT+0.66%INJUSDT+0.55%ATOMUSDT-1.34%STXUSDT-0.75%TIAUSDT-1.24%PYTHUSDT-2.20%FETUSDT+3.93%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.70%OPUSDT-0.20%WIFUSDT-0.06%IOTAUSDT+0.44%POLUSDT+1.00%AXSUSDT+0.72%EOSUSDT+1.31%FARTCOINUSDT+2.24%DYDXUSDT+2.78%GALAUSDT+0.98%ORDIUSDT+1.96%RONINUSDT+1.89%NOTUSDT+1.92%NVDA+0.71%AAPL+0.57%MSFT-0.38%GOOGL+1.55%AMZN+1.94%TSM+3.07%SPCX+1.80%AVGO+3.94%META-1.29%TSLA+3.69%LLY+0.06%BRK-B-0.82%MU+3.14%SKHY+2.46%WMT-1.14%AMD+5.31%JPM+0.62%V-1.52%XOM-2.13%JNJ+0.91%ASMLa+2.80%MA-1.07%ABBV-0.09%INTC+3.21%1398.HK+2.15%CVX-1.44%0700.HK-0.31%COST-1.40%CSCO+1.03%KO-1.31%ORCL+4.53%UNH-0.14%PG-0.63%BAC+0.33%1816.HK+1.32%3988.HK+0.66%CAT+2.90%DELL+7.60%HD-0.08%PM+0.49%0857.HK-0.98%0939.HK+0.81%AMAT+1.99%AP2d+2.18%GE+3.35%1288.HK+0.60%LRCX+1.29%0005.HK-5.56%NVS+1.62%MS+2.07%NZDMXN+0.67%USDJPY+0.67%USDMXN+0.60%EURUSD-0.60%AUDJPY+0.57%AUDDKK+0.52%EURAUD-0.50%EURZAR-0.50%GBPUSD-0.44%USDCHF+0.43%EURSEK-0.43%GBPTRY+0.41%EURCNH-0.40%NZDJPY+0.40%GBPZAR-0.36%EURHKD-0.36%CADJPY+0.35%EURNZD-0.35%GBPAUD-0.35%AUDCHF+0.35%USDDKK+0.35%EURSGD-0.34%USDCAD+0.33%GBPHKD+0.32%GBPMXN-0.28%USDPLN+0.27%AUDNOK+0.27%NZDUSD-0.26%EURCAD-0.26%CHFJPY+0.25%SGDJPY+0.25%EURNOK-0.25%AUDCAD+0.23%GBPJPY+0.21%GBPSGD-0.20%EURCHF-0.18%CHFSEK-0.18%GBPNZD-0.18%AUDSGD+0.18%USDTRY+0.18%NZDCHF+0.16%USDILS+0.16%NOKJPY+0.16%AUDNZD+0.16%EURGBP-0.15%USDZAR-0.14%GBPCAD-0.13%USDNOK+0.10%CADCHF+0.10%AUDUSD-0.09%CHFSGD-0.09%USDSEK-0.08%EURPLN-0.08%EURJPY+0.08%NZDSGD+0.08%NZDCAD+0.06%USDCNH-0.05%EURCZK-0.04%USDHKD+0.04%USDCOP-0.04%GBPCHF-0.03%USDTHB-0.02%USDSGD+0.01%CHFNOK+0.01%PLNJPY-0.01%EURDKK0.00%HG1+1.70%USOIL-1.24%XNGUSD-1.14%XAUUSD+0.97%GAUUSD+0.97%UKOIL-0.87%XAGUSD+0.47%GAGUSD+0.47%XPTUSD+0.09%SUGAR0.00%COTTON0.00%C10.00%BTCUSD+0.73%ETHUSD+23.96%USDTUSD+0.06%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.16%ZECUSDT+5.59%DOGEUSD+20.65%XMRUSDT+0.37%LINKUSD+25.58%BCHUSDT+3.29%XLMUSD+0.44%UNIUSD-0.51%LTCUSD+17.89%SUIUSD+0.88%HBARUSDT-1.75%TONUSD+41.71%TAOUSDT+0.59%AAVEUSD-2.45%DOTUSDT-0.79%ICPUSDT-1.33%ONDOUSDT+0.41%WLDUSDT+0.37%ARBUSDT-0.06%JUPUSDT+0.66%INJUSDT+0.55%ATOMUSDT-1.34%STXUSDT-0.75%TIAUSDT-1.24%PYTHUSDT-2.20%FETUSDT+3.93%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+0.70%OPUSDT-0.20%WIFUSDT-0.06%IOTAUSDT+0.44%POLUSDT+1.00%AXSUSDT+0.72%EOSUSDT+1.31%FARTCOINUSDT+2.24%DYDXUSDT+2.78%GALAUSDT+0.98%ORDIUSDT+1.96%RONINUSDT+1.89%NOTUSDT+1.92%
CB

Cytek Biosciences, Inc. (CTKB)

NASDAQ • Healthcare

$5.89
+$0.29 (+5.4%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$5.6
Previous Close$5.89
Day Range$5.59 - $5.9
Avg. Volume (3M)1.3M
Market Cap$769.3M
52 Week Range
$3.31$6.21
Next EarningsIn 8 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$48.1M100%
Gross Profitminus cost of goods$28.3M59%

In plain terms: out of every $100 in revenue, Cytek Biosciences, Inc. currently loses $25.

Fundamentals & Financials

Revenue (TTM)
$206.7M
Net Income (TTM)
-$80.5M
EPS (TTM)
-$0.62
ROA (TTM)
-18.03%
Current Ratio
4.48

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-1600.0%Q1 2026-$0.34
-50.0%Q2 2026-$0.12
+46.4%Q3 2026-$0.05
Next

Nov 4

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Cytek Biosciences, Inc. (CTKB) reports earnings on November 4, 2026. Wall Street is looking for consensus EPS of -$0.07 on revenue of $52.9 million. For trailing context, revenue grew +5.6% year over year last quarter. Cytek has beaten EPS in 4 of its 8 most recent quarters.

View full earnings history

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (NASDAQ: CTKB) makes cell analysis instruments and related consumables and software for the healthcare equipment market. Its spectrum flow cytometry and cell sorting platform serves biomedical research and clinical settings, and the company recorded $201.5 million of revenue in FY2025.

Name
Cytek Biosciences, Inc.
CEO
Wenbin Jiang
Website
cytekbio.com
Industry
Healthcare
Year Founded
1992
Employees
682

Today's Snapshot

AI-generated

CTKB is trading 0.6% above yesterday's close, while its sector was flat. CTKB remains within 4.6% of its 52-week high of 6.21. CTKB is due to report earnings on 4 November.

Trading Volume

Below 10d avg (862.4K)

360.9K

vs S&P 500 Today

Inline with Market

-0.10%

Updated: October 27, 2026 at 16:52 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
CTKB is trading above its short-, medium- and long-term moving averages, reflecting a constructive price posture while MACD and CCI show bullish momentum. The RSI is firm but not extreme, and ADX is low-to-moderate, suggesting the trend is present but not yet strongly directional. On-balance volume is supportive, indicating accumulation alongside rising prices, while ATR points to moderate volatility in the mid-single-digit percentage range. The classic pivot sits near the market but is not a major impediment. Technical takeaway: Buy—price and volume support an upward bias with modest trend strength.
All signals
  • EMA (5 indicators)$4.85 - $5.60
    Buy
  • RSI (14)65.88
    Neutral
  • Stochastic %K (14, 3, 3)80.54
    Sell
  • MACD Level (12, 26)0.12
    Buy

Peers & Related Assets

AAgilent Technologies, Inc.
$175.96+1.7%
BIOBio-Rad Laboratories, Inc.
$372.43+0.7%
TXG10x Genomics, Inc.
$72.96+2.0%
BRKRBruker Corporation
$58.23+1.1%
LABStandard BioTools Inc.
$0.6-0.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.